AMX-213

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAMX-213
Drug Alias Nameghrelin modulator (Amunix)ghrelin-XTENAMX-213
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGhrelin modulators
TargetsGhrelin
Therapy Area/IndicationsCachexiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmunix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCachexiaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A